GTN

Bringing a single new drug to the market costs $2.9bn, often delivering an intervention that barely differs from those already in the market. Projections into the future are not promising, with an expected 50% drop in R&D output every nine years. At GTN they are searching the astronomically large space of drug-like molecules with their unique patented technology, Generative Tensorial Networks. Their software combines and builds upon techniques from machine learning and quantum physics to simulate, filter and search for molecules, halving development costs and discovering molecules entirely hidden from view.

#People #Financial #Event #Website #More

GTN

Social Links:

Twitter

Industry:

Biotechnology Chemical Machine Learning Quantum Computing

Founded:

2017-05-17

Address:

London, England, United Kingdom

Country:

United Kingdom

Website Url:

http://www.gtn.ai

Total Employee:

Status:

Closed

Email Addresses:

[email protected]

Total Funding:

2.84 M USD

Technology used in webpage:

Viewport Meta IPhone / Mobile Compatible SPF Mobile Non Scaleable Content Nginx DigiCert SSL CloudFront Japanese Yen Google Adsense CPanel

Current Advisors List

ali-alavi_image

Ali Alavi Advisor @ GTN
Advisor

Founder

noor-shaker_image

Noor Shaker

vid-stojevic_image

Vid Stojevic

Investors List

isomer-capital_image

Newest Events participated

Participated in Deep Learning in Healthcare Summit, London 2018 on 2018-09-20 as exhibitor

Participated in Deep Learning Summit London 2018 on 2018-09-20 as exhibitor

Participated in TechCrunch Meetup + Pitch-off: London 2017 on 2017-07-19 as exhibitor

Official Site Inspections